Elo Mutual Pension Insurance Co Purchases 4,027 Shares of Agilent Technologies, Inc. (NYSE:A)

Elo Mutual Pension Insurance Co raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 15.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,781 shares of the medical research company’s stock after acquiring an additional 4,027 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Agilent Technologies were worth $4,001,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sienna Gestion lifted its stake in shares of Agilent Technologies by 29.8% in the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock valued at $10,537,000 after buying an additional 17,991 shares during the period. Vestal Point Capital LP bought a new stake in Agilent Technologies in the third quarter valued at about $14,848,000. Sequoia Financial Advisors LLC grew its stake in shares of Agilent Technologies by 8.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock valued at $4,554,000 after purchasing an additional 2,664 shares during the period. S.E.E.D. Planning Group LLC grew its position in Agilent Technologies by 12.7% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after acquiring an additional 4,805 shares during the period. Finally, Daiwa Securities Group Inc. increased its position in shares of Agilent Technologies by 16.0% during the 4th quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company’s stock worth $6,621,000 after purchasing an additional 6,802 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Citigroup raised their price objective on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday, February 27th. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $150.83.

Agilent Technologies Stock Down 2.0 %

Shares of Agilent Technologies stock opened at $116.55 on Friday. The firm has a market cap of $33.23 billion, a PE ratio of 26.79, a P/E/G ratio of 3.34 and a beta of 1.11. The business’s 50 day simple moving average is $134.29 and its 200 day simple moving average is $136.65. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a 52-week low of $116.36 and a 52-week high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.